ITMCTR2100005211招募中1 期
Study on the clinical efficacy of Yiqi Huoxue Jiedu formula in the treatment of platinum resistant ovarian cancer based on the phenotypic changes of macrophages
Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 70(—)
- 性别
- Female
入选标准
- •1. Patients with primary epithelial ovarian cancer were diagnosed by surgical pathology;
- •2. Relapse within 6 months after the last platinum based chemotherapy withdrawal, or progress during chemotherapy;
- •3. The syndrome type of traditional Chinese medicine is Qi deficiency and blood stasis syndrome. The syndrome differentiation refers to the guiding principles for clinical research of new traditional Chinese medicine. The Qi deficiency syndrome and blood stasis syndrome are completed under the guidance of the chief physician of traditional Chinese medicine. Qi deficiency syndrome: it is necessary to differentiate between light tongue, light fat tongue, tooth marks on the edge of light tongue and two of shortness of breath, fatigue, spontaneous sweating, weak pulse or weak pulse; Blood stasis syndrome: facial ecchymosis, pain, precordial pain, limb numbness, hemiplegia, wrong skin nail, dark complexion, menstrual blood clot, dark tongue, ecchymosis, blue and purple sublingual vein. Syndrome differentiation can be achieved if there are 2 or more;
- •4. ECoG score: 0-1;
- •5. Estimated survival time >= 2 months;
- •6. Sign informed consent.
排除标准
- •1. Previous history of other tumors;
- •2. those with infectious diseases or immune system diseases have not yet been controlled;
- •3. Recent use of immunosuppressants;
- •4. Suffering from serious heart, liver, kidney and hematopoietic diseases without control;
- •5. Accompanied by mental illness, severe neurological deficit (such as aphasia and agnosia) or unable to cooperate with the investigation due to other reasons;
- •6. Those who are allergic to the drugs in this prescription.
研究者
相似试验
招募中
1 期
A clinical study on the efficacy of Yiqi Huayu Jiedu decoction for reducing the risk of postoperative recurrence and metastasis of gastric cancer Protocol for a multicenter, randomized, double-blind, placebo-controlled trialgastric cancerITMCTR2100004250Department of Oncology, Jiangsu Province Hospital of Chinese Medicine
招募中
不适用
Clinical Efficacy Observation of Yiqi Huoxue Prescription in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome After PCIITMCTR2100004215Affiliated Hospital of Chengdu University of traditional Chinese Medicine
已完成
不适用
Study on clinical efficacy of Qidong Huoxue Yin in the treatment of acute lung injuryacute lung injuryITMCTR2100005190The Second Affiliated Hospital of Zhengjiang University of Chinese Medicine
招募中
4 期
Clinical study on the efficacy and safety of Jieyuwan in the treatment of epidemic stress, anxiety and depression (stagnation of liver Qi syndrome)Anxiety and depressionITMCTR2100004368Dongfang Hospital Beijing University of Chinese Medicine
招募中
1 期
Clinical Efficacy Evaluation of Jianpi Huoxue Decoction in the Treatment of Non-alcoholic Fatty Liver DiseaseITMCTR2100004809Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine
